Simultaneous pulmonary and systemic blood pressure and ECG interval measurement in conscious, freely moving rats

Journal of the American Association for Laboratory Animal Science

Volumn 51, Issue 2, 2012, Pages 231-238

  Rey, Markus ^a   Weber, Edgar W ^a   Hess, Patrick D ^a  

^a ACTELION PHARMACEUTICALS LTD   (Switzerland)

Author keywords

MAP, mean arterial pressure; MPAP, mean pulmonary arterial pressure

Indexed keywords

ACCURACY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE; CATHETER; CONTROLLED STUDY; DESCENDING AORTA; ELECTROCARDIOGRAM; ELECTRODE; ELECTROPHYSIOLOGY; LUNG ARTERY PRESSURE; MALE; NONHUMAN; PULMONARY ARTERY; PULMONARY HYPERTENSION; RAT; TELEMETRY;

ANIMALS; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CATHETERS; ELECTROCARDIOGRAPHY, AMBULATORY; HYPERTENSION; MALE; MONOCROTALINE; PULMONARY ARTERY; RATS; RATS, WISTAR; TELEMETRY;

RATTUS; RATTUS NORVEGICUS;

EID: 84859117824     PISSN: 15596109     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Adeyemi O, Roberts S, Harris J, West H, Shome S, Dewhurst M. 2009. QA interval as an indirect measure of cardiac contractility in the conscious telemeterised rat: model optimization and evaluation. J Pharmacol Toxicol Methods 60:159-166.
2. Brockway B, Mills P, Azar S. 1991. A new method for continuous chronic measurement and recording of blood pressure, heart rate, and activity in the rat via radiotelemetry. Clin Exp Hypertens A 13:885-895.
3. Channick RN, Simonneau G, Sitbon O, Robbins IM, Frost A, Tapson VF, Badesch DB, Roux S, Rainisio M, Bodin F, Rubin LJ. 2001. Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomized placebo-controlled study. Lancet 358:1119-1123. (Pubitemid 32971843)
4. Clozel M, Hess P, Rey M, Iglarz M, Binkert C, Qiu C. 2006. Bosentan, sildenafil, and their combination in the monocrotaline model of pulmonary hypertesion in rats. Exp Biol Med (Maywood) 231:967-973. (Pubitemid 43845561)
5. Gillespie MN, Olson JW, Reinsel CN, O'Connor WN, Altiere RJ. 1986. Vascular hyperresponsiveness in perfused lungs from monocrotaline-treated rats. Am J Physiol 251:H109-H114.
6. Griffin KA, Picken M, Bakris G, Bidani A. 1999. Class differences in the effects of calcium channel blockers in the rat remnant kidney model. Kidney Int 55:1849-1860. (Pubitemid 29197972)
7. Hess P, Clozel M, Clozel JP. 1996. Telemetry monitoring of pulmonary arterial pressure in freely moving rats. J Appl Physiol 81:1027-1032. (Pubitemid 26303261)
8. Ilkiw R, Todorovich-Hunter L, Maruyama K, Shin J, Rabinovitch M. 1989. SC39026, a serine elastase inhibitor, prevents muscularization of peripheral arteries, suggesting a mechanism of monocrotaline-induced pulmonary hypertension in rats. Circ Res 64:814-825. (Pubitemid 19105317)
9. Meyrick B, Gamble W, Reid L. 1980. Development of Crotalaria pulmonary hypertension: hemodynamic and structural study. Am J Physiol 239:H692-H702.
10. Molteni A, Ward WF, Ts'ao CH, Port CD, Solliday NH. 1984. Monocrotaline-induced pulmonary endothelial dysfunction in rats. Proc Soc Exp Biol Med 176:88-94.
11. Rey M, Hess P, Clozel M. 2009. Monocrotaline-induced pulmonary hypertension in Wistar rats. Curr Prot Pharmacol 46:5.56.1-5-.56.11.
12. Rubin LJ, Badesch DB, Barst RJ, Galie N, Black CM, Keogh A, Pulido T, Frost A, Roux S, Leconte I, Landzberg M, Simonneau G. 2002. Bosentan therapy for pulmonary arterial hypertension. N Engl J Med 346:896-903. (Pubitemid 34984638)
13. Schmidlin O, Garcia J, Schwartz J. 1991. The effects of aging on the electrophysiologic responses to verapamil in isolated perfused rat hearts. J Pharmacol Exp Ther 258:130-135.
14. Tandon A, Simpson L, Assar M. 2011. Unusual origin of type 1 atrioventricular block with comments on Wenckebach's contribution. Proc (Bayl Univ Med Cent) 24:9-12.